MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$17.92 -0.88 (-4.68%)
Open Price: 18.49
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients